- Policy
- It's hard to prescribe oral medicine for COVID-19
- by Kim, Jung-Ju Aug 9, 2022 05:56am
- Amid the remarkable re-proliferation of COVID-19, the newly proposed National Infectious Disease Crisis Response Advisory Committee advised medical staff to create detailed guidelines for prescriptions in consideration of difficulties in the dispensing process. The National Advisory Committee on Infectious Disease Crisis Response (Chairman
- Policy
- MFDS beings rolling review of Pfizer’s multivalent vaccine
- by Lee, Hye-Kyung Aug 8, 2022 06:09am
- The Ministry of Food and Drug Safety (Minister: Yu-Kyoung Oh) announced that it had started a rolling review on the clinical trial data that Pfizer Korea submitted on the 5th for its COVID-19 vaccine ‘Comirnaty2 Inj. 0.1mg/mL.' Comirnaty2 Inj. 0.1mg/mL. is a multivalent mRNA vaccine that presents antigens for both the original COVID-19 v
- Policy
- 500 billion won in K-Bio and Vaccine Fund was created
- by Kim, Jung-Ju Aug 8, 2022 06:09am
- The government has finalized a plan to create a K-Bio and Vaccine Fund" worth a total of 500 billion won this year and has started selecting operators. In the future, the government plans to expand the scale to around 1 trillion won. The MOHW (first vice minister Cho Kyu-hong) announced on the 4th that it will report and confirm the plan to c
- Policy
- Supply of Children's Tylenol suspension will be normalized
- by Lee, Tak-Sun Aug 7, 2022 11:30pm
- The product license was withdrawn due to the suspension of the operation of the Jansen Hyangnam plant in Korea, but the new product re-licensed due to technology transfer will be listed as starting in August. This includes child Tylenol suspension, and attention is being paid to whether supply and demand will be normalized with new benefits,
- Policy
- Security elaboration/ ultra-high-priced new drug coverage
- by Kim, Jung-Ju Aug 5, 2022 06:04am
- In order to strengthen accessibility to new drug patients, the government has steadily increased coverage by opening a benefit gateway. However, due to the development of innovative new drugs, limited funding of health insurance is a problem to catch up with the ultra-high price trend of anticancer drugs and rare disease treatments. The chall
- Policy
- MOHW reluctant to CVS's request to expand SRADs
- by kang, hae-kyung Aug 5, 2022 06:04am
- The Ministry of Health and Welfare expressed disapproval over the convenience store industry's request that the scope of Safe and Readily Available Drugs (SRADs) should be expanded to antacids and burn ointments for sale at convenience stores. The MOHW explained that the SRAD system is a unique exception made from the healthcare system’s
- Policy
- Biogen’s Alzheimer’s disease TX entry unclear in Korea
- by Lee, Hye-Kyung Aug 4, 2022 06:05am
- Introduction of the world’s first Alzheimer’s disease treatment, ‘Aduhelm (aducanumab),’ has virtually become unclear in Korea. The results of the Central Pharmaceutical Affairs Council meeting that was held on July 12th that was recently disclosed by the Ministry of Food and Drug Safety showed that the expert advisory board concluded
- Policy
- Mandatory notification for correctional facilities
- by Kim, Jung-Ju Aug 2, 2022 06:02am
- A bill that stipulates that the MFDS should also notify the MFDS of narcotics prescriptions conducted at correctional facilities and military units will be promoted. Representative Choi Yeon-sook of the People's Power represented the partial revision bill of the Drug Management Act. With the increase in the handling of medical narcotics, t
- Policy
- Daewoong sells the original Ebixa
- by Lee, Tak-Sun Aug 1, 2022 09:16pm
- Daewoong Pharmaceutical, which once sought to develop a high-dose dementia treatment Ebixa, sells original drug in Korea instead of giving it up. Ebixa 20mg, a higher dose than the existing product, is expected to greatly improve the convenience of taking it because patients only need to eat one dose a day. According to the industry on the 29
- Policy
- MFDS Minister promises COVID-19 vaccineˑTx support
- by Lee, Hye-Kyung Aug 1, 2022 05:58am
- The Minister of Food and Drug Safety Yoo-Kyung Oh met with COVID-19 vaccine and treatment developers and relevant associations and promised support in the future. On the 29th, the MFDS held an MFDS-Industry roundtable meeting for the COVID-19 vaccine-treatment development support. The meeting was held to discuss the difficulties experie
